Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Carbone

Showing results (411-420 of 651) with videos related to

Pageof 66
Sort By:
Nature Medicine|October 1, 1996
Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cellsD I Gabrilovich, H L Chen, K R Girgis, et al.
Annals of Internal Medicine|January 1, 1973
Training program in medical oncologyB J Kennedy, P Calabresi, P P Carbone, et al.
Lung Cancer (Amsterdam, Netherlands)|June 8, 2020
Clinical and Molecular Correlates of Tumor Mutation Burden in Non-Small Cell Lung CancerMichael F Sharpnack, Ju Hwan Cho, Travis S Johnson, et al.
Chest|December 1, 1994
p53 immunostaining positivity is associated with reduced survival and is imperfectly correlated with gene mutations in resected non-small cell lung cancer. A preliminary report of LCSG 871D P Carbone, T Mitsudomi, I Chiba, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1984
Aggressive combined modality therapy for advanced local-regional breast carcinomaC L Loprinzi, P P Carbone, D C Tormey, et al.
Iscience|July 24, 2023
Moderate-intensity endurance training improves late phase β-cell function in adults with type 2 diabetesHui Zhang, Laura K Simpson, Nicholas P Carbone, et al.
Cancer|February 1, 1979
Eastern Cooperative Oncology Group experience with the rappaport classification of non-Hodgkin's lymphomasE Z Ezdinli, W Costello, L P Wasser, et al.
Journal of Cancer Metastasis and Treatment|November 15, 2021
RANBP9 as potential therapeutic target in non-small cell lung cancerAnna Tessari, Shimaa H A Soliman, Arturo Orlacchio, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 21, 2000
Increased production of immature myeloid cells in cancer patients: a mechanism of immunosuppression in cancerB Almand, J I Clark, E Nikitina, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 17, 2005
Targeting cyclooxygenase-2 in recurrent non-small cell lung cancer: a phase II trial of celecoxib and docetaxelIldiko Csiki, Jason D Morrow, Alan Sandler, et al.
Pageof 66

Showing results (411-420 of 651) with videos related to

Sort By:
Pageof 66
Nature Medicine|October 1, 1996
Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cellsD I Gabrilovich, H L Chen, K R Girgis, et al.
Annals of Internal Medicine|January 1, 1973
Training program in medical oncologyB J Kennedy, P Calabresi, P P Carbone, et al.
Lung Cancer (Amsterdam, Netherlands)|June 8, 2020
Clinical and Molecular Correlates of Tumor Mutation Burden in Non-Small Cell Lung CancerMichael F Sharpnack, Ju Hwan Cho, Travis S Johnson, et al.
Chest|December 1, 1994
p53 immunostaining positivity is associated with reduced survival and is imperfectly correlated with gene mutations in resected non-small cell lung cancer. A preliminary report of LCSG 871D P Carbone, T Mitsudomi, I Chiba, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1984
Aggressive combined modality therapy for advanced local-regional breast carcinomaC L Loprinzi, P P Carbone, D C Tormey, et al.
Iscience|July 24, 2023
Moderate-intensity endurance training improves late phase β-cell function in adults with type 2 diabetesHui Zhang, Laura K Simpson, Nicholas P Carbone, et al.
Cancer|February 1, 1979
Eastern Cooperative Oncology Group experience with the rappaport classification of non-Hodgkin's lymphomasE Z Ezdinli, W Costello, L P Wasser, et al.
Journal of Cancer Metastasis and Treatment|November 15, 2021
RANBP9 as potential therapeutic target in non-small cell lung cancerAnna Tessari, Shimaa H A Soliman, Arturo Orlacchio, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 21, 2000
Increased production of immature myeloid cells in cancer patients: a mechanism of immunosuppression in cancerB Almand, J I Clark, E Nikitina, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 17, 2005
Targeting cyclooxygenase-2 in recurrent non-small cell lung cancer: a phase II trial of celecoxib and docetaxelIldiko Csiki, Jason D Morrow, Alan Sandler, et al.
Pageof 66